Evaluation of pretherapeutic Ki67 as predictive marker for response to neoadjuvant chemotherapy in patients with primary breast cancer.

被引：0
|
作者：
Farr, Alex
Weber, Myriam
Pfeiler, Georg
Oppolzer, Elisabeth
Salama, Mohammed
Bago-Horvath, Zsuzsanna
Seifert, Michael
Singer, Christian F.
机构：
[1] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria
[2] Otto Wagner Hosp, Div Thorac Surg, Vienna, Austria
[3] Med Univ Vienna, Clin Inst Pathol, Vienna, Austria
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e12500
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12500
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Evaluation of Ki67 proliferation index before and during neoadjuvant chemotherapy for primary breast cancer.
    Burcombe, RJ
    Makris, A
    Richman, PI
    Daley, F
    Pittam, M
    Wilson, GD
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S67 - S67
  • [2] The role of Ki67 in involved lymph nodes as a predictive biomarker for response to neoadjuvant chemotherapy in patients with early breast cancer.
    Kolberg-Liedtke, Cornelia
    Hussein, Shady
    Bankfalvi, Agnes
    Steinborn, Julia
    Ting, Saskia
    Bittner, Ann-Kathrin
    Hoffmann, Oliver
    Pott, Birgit
    Hannig, Carla Verena
    Wetzig, Sarah
    Kolberg, Hans-Christian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] Clinical significance of pretherapeutic Ki67 as a predictive parameter for response to neoadjuvant chemotherapy in breast cancer; is it equally useful across tumor subtypes?
    Sueta, Aiko
    Yamamoto, Yutaka
    Hayashi, Mitsuhiro
    Yamamoto, Satoko
    Inao, Toko
    Ibusuki, Mutsuko
    Murakami, Keiichi
    Iwase, Hirotaka
    [J]. SURGERY, 2014, 155 (05) : 927 - 935
  • [4] Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer
    von Minckwitz, Gunter
    Schmitt, Wolfgang D.
    Loibl, Sibylle
    Mueller, Berit M.
    Blohmer, Jens U.
    Sinn, Bruno V.
    Eidtmann, Holger
    Eiermann, Wolfgang
    Gerber, Bernd
    Tesch, Hans
    Hilfrich, Joern
    Huober, Jens
    Fehm, Tanja
    Barinoff, Jana
    Ruediger, Thomas
    Erbstoesser, Erhard
    Fasching, Peter A.
    Karn, Thomas
    Mueller, Volkmar
    Jackisch, Christian
    Denkert, Carsten
    [J]. CLINICAL CANCER RESEARCH, 2013, 19 (16) : 4521 - 4531
  • [5] Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
    Peter A Fasching
    Katharina Heusinger
    Lothar Haeberle
    Melitta Niklos
    Alexander Hein
    Christian M Bayer
    Claudia Rauh
    Ruediger Schulz-Wendtland
    Mayada R Bani
    Michael Schrauder
    Laura Kahmann
    Michael P Lux
    Johanna D Strehl
    Arndt Hartmann
    Arno Dimmler
    Matthias W Beckmann
    David L Wachter
    [J]. BMC Cancer, 11
  • [6] Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
    Fasching, Peter A.
    Heusinger, Katharina
    Haeberle, Lothar
    Niklos, Melitta
    Hein, Alexander
    Bayer, Christian M.
    Rauh, Claudia
    Schulz-Wendtland, Ruediger
    Bani, Mayada R.
    Schrauder, Michael
    Kahmann, Laura
    Lux, Michael P.
    Strehl, Johanna D.
    Hartmann, Arndt
    Dimmler, Arno
    Beckmann, Matthias W.
    Wachter, David L.
    [J]. BMC CANCER, 2011, 11
  • [7] Ki67 as a Predictive Marker of Response to Neoadjuvant Chemotherapy in Patients with Early-Stage Breast Cancer (ESBC): A Systematic Review and Evidence Summary
    Lyman, G. H.
    Culakova, E.
    Poniewierski, M. S.
    Wogu, A. F.
    Barry, W.
    Ginsburg, G. S.
    Marcom, P. K.
    Ready, N.
    Abernethy, A.
    Geradts, J.
    Hwang, S.
    Kuderer, N. M.
    [J]. CANCER RESEARCH, 2012, 72
  • [8] KI67 AS A PREDICTOR OF CLINICAL RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN TRIPLEPOSITIVE BREAST CANCER
    Ben Hamida, Karim
    Houcine, Yoldez
    Maaoui, Amal
    Hamza, Khedija
    Kamoun, Salma
    Ayadi, Senda
    Chargui, Riadh
    Driss, Maha
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A59 - A59
  • [9] Studies of the Potential Utility of Ki67 as a Predictive Molecular Marker of Clinical Response in Primary Breast Cancer
    L. Assersohn
    J. Salter
    T.J. Powles
    R. A'hern
    A. Makris
    R.K. Gregory
    J. Chang
    M. Dowsett
    [J]. Breast Cancer Research and Treatment, 2003, 82 : 113 - 123
  • [10] Studies of the potential utility of Ki67 as a predictive molecular marker of clinical response in primary breast cancer
    Assersohn, L
    Salter, J
    Powles, TJ
    A'hern, R
    Makris, A
    Gregory, RK
    Chang, J
    Dowsett, M
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 (02) : 113 - 123
12345